Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 1,039 | 0 | 0 | 0 | 0 |
| Gross Profit | 1,039 | N/A | N/A | N/A | N/A |
| Operating Expenses | 25,768 | 102,337 | 25,885 | 21,030 | 14,224 |
| Operating Income | -24,729 | -91,493 | -25,885 | -21,030 | -14,224 |
| Interest Expense | 0 | 0 | 0 | 1,073 | 1,112 |
| Other Income | 1,446 | 1,096 | 1,278 | 313 | 188 |
| Pre-tax Income | -23,283 | -90,397 | -24,607 | -21,790 | -15,148 |
| Net Income Continuous | -23,283 | -92,397 | -24,607 | -21,790 | -15,148 |
| Net Income | $-23,283 | $-92,397 | $-24,607 | $-21,790 | $-15,148 |
| EPS Basic Total Ops | -0.70 | 13.02 | -1.27 | -4.93 | -19.63 |
| EPS Basic Continuous Ops | -0.77 | 11.98 | -1.49 | -5.65 | -19.62 |
| EPS Diluted Total Ops | -0.70 | 13.02 | -1.27 | -4.93 | -19.63 |
| EPS Diluted Continuous Ops | -0.77 | 11.98 | -1.49 | -5.65 | -19.62 |
| EPS Diluted Before Non-Recurring Items | -0.70 | -4.01 | -1.27 | -4.93 | -4.00 |
| EBITDA(a) | $-24,665 | $-102,283 | $-25,857 | $-21,030 | $-14,224 |